Variability in the Diagnosis and Management of Patients with Alzheimer's Disease and Cerebrovascular Disease: Results from the GALATEA Multicentre, Observational Study

Author： Gil Pedro  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.28, Iss.7, 2008-01, pp. : 429-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Tolerability of Donepezil at Doses up to 20 mg/day: Results from a Pilot Study in Patients with Alzheimer's Disease

By Doody Rachelle S.  

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 163-174

Adis International

Access to resources Recommend Favorite

Diagnosis and Treatment of Patients with Severe Alzheimer's Disease

By Voisin Thierry  

Drugs & Aging, Vol. 26, Iss. 2, 2009-01 ,pp. : 135-144

Adis International

Access to resources Recommend Favorite

Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin: Final Results from an Open-Label, Observational, Multicentre Study

By Wild John M.  

CNS Drugs, Vol. 23, Iss. 11, 2009-11 ,pp. : 965-982

Adis International

Access to resources Recommend Favorite

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

By Rogers S.L.   Friedhoff L.T.  

European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Galantamine is beneficial in both patients with vascular dementia and patients with Alzheimer's disease with cerebrovascular disease

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite